Complement Activation by Direct C4 Binding to Thyroperoxidase in Hashimoto's Thyroiditis

Endocrinology

Volumn 144, Issue 12, 2003, Pages 5422-5429

  Blanchin, Stéphanie ^a   Estienne, Valérie ^a   Durand Gorde, Josée Martine ^a   Carayon, Pierre ^a   Ruf, Jean ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; COMPLEMENT COMPONENT C4 BINDING PROTEIN; EPIDERMAL GROWTH FACTOR; HYDROXYL RADICAL; IMMUNOGLOBULIN; METHIONINE; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; THYROID HORMONE; THYROID PEROXIDASE;

ARTICLE; AUTOIMMUNITY; BIOSYNTHESIS; CELL DESTRUCTION; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; ENZYME ACTIVATION; ENZYME BINDING; GENE OVEREXPRESSION; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR MECHANICS; NORMAL HUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; THYROID CELL; THYROID FUNCTION;

ACUTE DISEASE; COMPLEMENT ACTIVATION; COMPLEMENT C2; COMPLEMENT C3; COMPLEMENT C4; COMPLEMENT C5; COMPLEMENT C6; COMPLEMENT C7; COMPLEMENT C8; COMPLEMENT C9; GENE EXPRESSION; HUMANS; IODIDE PEROXIDASE; REACTIVE OXYGEN SPECIES; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 0345688683     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-0918     Document Type: Article

References (46)

1. Weetman AP, McGregor AM 1994 Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 15:788-830
2. Rapoport B, McLachlan SM 2001 Thyroid autoimmunity. J Clin Invest 108: 1253-1259
3. Sugawara M, Sugawara Y, Wen K, Giulivi C 2002 Generation of oxygen free radicals in thyroid cells and inhibition of thyroid peroxidase. Exp Biol Med (Maywood) 227:141-146
4. Duthoit C, Estienne V, Delom F, Durand-Gorde JM, Mallet B, Carayon P, Ruf J 2000 Production of immunoreactive thyroglobulin C-terminal fragments during thyroid hormone synthesis. Endocrinology 141:2518-2525
5. Esquivel PS, Rose NR, Kong YC 1977 Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide. J Exp Med 145:1250-1263
6. Chiovato L, Bassi P, Santini F, Mammoli C, Lapi P, Carayon P, Pinchera A 1993 Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 77:1700-1705
7. Rodien P, Madec AM, Ruf J, Rajas F, Bornet H, Carayon P, Orgiazzi J 1996 Antibody-dependent cell mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies. J Clin Endocrinol Metab 81:1211-1218
8. Kohno Y, Hiyama Y, Shimojo N, Niimi H, Nakajima H, Hosoya T 1986 Autoantibodies to thyroid peroxidase in patients with chronic thyroiditis: effect of antibody binding on enzyme activities. Clin Exp Immunol 65:534-541
9. Estienne V, Blanchet C, Niccoli-Sire P, Duthoit C, Durand-Gorde JM, Geourjon C, Baty D, Carayon P, Ruf J 1999 Molecular model, calcium sensitivity, and disease specificity of a conformational thyroperoxidase B-cell epitope. J Biol Chem 274:35313-35317
10. Thielens NM, Bersch B, Hernandez JF, Arlaud GJ 1999 Structure and functions of the interaction domains of C1r and C1s: keystones of the architecture of the C1 complex. Immunopharmacology 42:3-13
11. Matsushita M, Fujita T 1992 Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med 176:1497-1502
12. Mollnes TE, Song WC, Lambris JD 2002 Complement in inflammatory tissue damage and disease. Trends Immunol 23:61-64
13. Ziccardi RJ 1981 Activation of the early components of the classical complement pathway under physiologic conditions. J Immunol 126:1769-1773
14. Rossi V, Bally I, Thielens NM, Esser AF, Arlaud GH 1998 Baculovirus-mediated expression of truncated modular fragments from the catalytic region of human complement serine protease C1s. Evidence for the involvement of both complement control protein modules in the recognition of the C4 protein substrate. J Biol Chem 273:1232-1239
15. Zimmermann-Nielsen E, Svehag SE, Thorlacius-Ussing O, Baatrup G 2001 ELISA for evaluating the incorporation of plasma derived complement split-products C3b/iC3b into solid-phase immune complexes. J Immunol Methods 249:43-51
16. Marriq C, Rolland M, Lissitzky S 1977 Polypeptide chains of 19-S thyroglobulin from several mammalian species and of porcine 27-S iodoprotein. Eur J Biochem 79:143-149
17. Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S 1985 Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett 190:147-152
18. Blanchin S, Estienne V, Guo J, Rapoport B, McLachlan SM, Carayon P, Ruf J 2002 Human thyroperoxidase folds in one complex B-cell immunodominant region. Biochem. Biophys Res Commun 295:1118-1124
19. Estienne V, Duthoit C, Reichert M, Praetor A, Carayon P, Hunziker W, Ruf J 2002 Androgen-dependent expression of FcγRIIB2 by thyrocytes from patients with autoimmune Graves' disease: a possible molecular due for sex dependance of autoimmune disease. FASEB J 16:1087-1092
20. Zubler RH, Lange G, Lambert PH, Miescher PA 1976 Detection of immune complexes in unheated sera by modified 1251-C1q binding test. Effect of heating on the binding of C1q by immune complexes and application of the test to systemic lupus erythematosus. J Immunol 116:232-235
21. Klegeris A, Bissonnette CJ, Dorovini-Zis K, McGeer PL 2000 Expression of complement messenger RNAs by human endothelial cells. Brain Res 871:1-6
22. Ruf J, Toubert ME, Czarnocka B, Durand-Gorde JM, Ferrand M, Carayon P 1989 Relationship between immunological structure and biochemical properties of human thyroid peroxidase. Endocrinology 125:1211-1218
23. Schagger H, von Jagow G 1987 Tricine-sodium dodecyl sulfate- polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166:368-379
24. Halliwell B, Gutteridge JM 1990 Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186:1-85
25. Bradt BM, Kolb WP, Cooper NR 1998 Complement-dependent proinflammatory properties of the Alzheimer's disease β-peptide. J Exp Med 188:431-438
26. Bohmig GA, Exner M, Habicht A, Schillinger M, Lang U, Kletzmayr J, Saemann MD, Horl WH, Watschinger B, Regele H 2002 Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 13:1091-1099
27. Stassi G, De Maria R 2002 Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol 2:195-204
28. Taurog A 1996 Hormone synthesis: thyroid iodine metabolism. In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the thyroid. 7th ed. Philadelphia: Lippincott-Raven Publishers; 47-81
29. Delom F, Mallet B, Carayon P, Lejeune PJ 2001 Role of extracellular molecular chaperones in the folding of oxidized proteins. Refolding of colloidal thyroglobulin by protein disulfide isomerase and immunoglobulin heavy chain-binding protein. J Biol Chem 276:21337-21342
30. Galeazzi L, Ronchi P, Franceschi C, Giunta S 1999 In vitro peroxidase oxidation induces stable dimers of β-amyloid (1-42) through dityrosine bridge formation. Amyloid 6:7-13
31. Vogt W, Damerau B, von Zabern I, Nolte R, Brunahl D 1989 Non-enzymic activation of the fifth component of human complement, by oxygen radicals. Some properties of the activation product, C5b-like C5. Mol Immunol 26:1133-1142
32. Vogt W, Hesse H 1992 Activation of the fifth component of human complement by oxygen-derived free radicals, and by methionine oxidizing agents: a comparison. Immunobiology 184:384-391
33. Repine JE, Eaton JW, Anders MW, Hoidal JR, Fox RB 1979 Generation of hydroxyl radical by enzymes, chemicals, and human phagocytes in vitro. Detection with the anti-inflammatory agent, dimethyl sulfoxide. J Clin Invest 64:1642-1651
34. Morgan BP, Gasque P 1997 Extrahepatic complement biosynthesis: where, when and why? Clin Exp Immunol 107:1-7
35. Blanchong CA, Chung EK, Rupert KL, Yang Y, Yang Z, Zhou B, Moulds JM, Yu CY 2001 Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4. Int Immunopharmacol 1:365-392
36. Kulics J, Circolo A, Strunk RC, Colten HR 1994 Regulation of synthesis of complement protein C4 in human fibroblasts: cell-and gene-specific effects of cytokines and lipopolysaccharide. Immunology 82:509-515
37. Matsubayashi S, Akasu F, Kasuga Y, Snow K, Keystone E, Volpe R 1990 In vitro production of IFN-γ by peripheral blood frompatients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis. Clin Exp Immunol 82:63-68
38. Roura-Mir C, Catalfamo M, Sospedra M, Alcalde L, Pujol-Borrell R, Jaraquemada D 1997 Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto's thyroiditis and Graves' disease. Eur J Immunol 27:3290-3302
39. Guo J, Rapoport B, McLachlan SM 1999 Balance of Th1/Th2 cytokines in thyroid autoantibody synthesis in vitro. Autoimmunity 30:1-9
40. Weerman AP 2003 Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol 148:1-9
41. Kopf M, Abel B, Gallimore A, Carroll M, Bachmann MF 2002 Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat Med 8:373-378
42. Todd I, Pujol-Borrell R, Hammond LJ, Bottazzo GF, Feldmann M1985 IFN-γ induces HLA-DR expression by thyroid epithelium. Clin Exp Immunol 61: 265-273
43. Tandon N, Metcalfe RA, Barnett D, Weetman AP 1994 Expression of the costimulatory molecule B7/BB1 in autoimmune thyroid disease. Q J Med 87:231-236
44. Matsuoka N, Eguchi K, Kawakami A, Tsuboi M, Nakamura H, Kimura H, Ishikawa N, Ito K, Nagataki S 1996 Lack of B7-1/BB1 and B7-2/B70 expression on thyrocytes of patients with Graves' disease. Delivery of costimulatory signals from bystander professional antigen-presenting cells. J Clin Endocrinol Metab 81:4137-4143
45. Battifora M, Pesce G, Paolieri F, Fiorino N, Giordano C, Riccio AM, Torre G, Olive D, Bagnasco M 1998 B7.1 costimulatory molecule is expressed on thyroid follicular cells in Hashimoto's thyroiditis, but not in Graves' disease. J Clin Endocrinol Metab 83:4130-4139
46. Mathis D, Vence L, Benoist C 2001 β-Cell death during progression to diabetes. Nature 414:792-798